Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

2485 ARTÍCULOS , VIENDO DEL 481 AL 495

Different physical exercise in the treatment of Alzheimer's disease

Deng T, Yu W, Lü Y.

Psychogeriatrics. 2025 Jan;25(1):e13207. doi: 10.1111/psyg.13207. Epub 2024 Oct 26.

Therapeutic Potential of Polyphenols in Cellular Reversal of Patho-Mechanisms of Alzheimer's Disease Using In Vitro and In Vivo Models: A Comprehensive Review

Samal M, Srivastava V, Khan M, Insaf A, Penumallu NR, Alam A, Parveen B, Ansari SH, Ahmad S.

Phytother Res. 2025 Jan;39(1):25-50. doi: 10.1002/ptr.8344. Epub 2024 Nov 4.

Amyloid-beta antibody treatment in Alzheimer's disease : An update on recent data and outlook on implementation in clinical routine

Stögmann E, Schmidt R.

Wien Klin Wochenschr. 2025 Mar;137(5-6):182-188. doi: 10.1007/s00508-024-02466-7. Epub 2024 Nov 6.

Application of carbon-based nanomaterials in Alzheimer's disease

Bai M, Shao X, Wang C, Wang J, Wang X, Guan P, Hu X.

Mater Horiz. 2025 Feb 3;12(3):673-693. doi: 10.1039/d4mh01256a.

The Contribution of the Renin-Angiotensin System to Alzheimer's Disease

Güzel Ö, Kehoe PG.

Curr Top Behav Neurosci. 2025;69:107-127. doi: 10.1007/7854_2024_525.

A review on gut microbiota and miRNA crosstalk: implications for Alzheimer's disease

Ayyanar MP, Vijayan M.

Geroscience. 2025 Feb;47(1):339-385. doi: 10.1007/s11357-024-01432-5. Epub 2024 Nov 19.

Exploring DPP IV inhibitors for Alzheimer's disease: Bridging diabetes and neurodegeneration

Pattanaik S, Prusty SK, Sahu PK.

Brain Res. 2025 Feb 1;1848:149342. doi: 10.1016/j.brainres.2024.149342. Epub 2024 Nov 19.

Calcium balance through mutual orchestrated inter-organelle communication: A pleiotropic target for combating Alzheimer's disease

Hossain MK, Chae HJ.

Neurochem Int. 2025 Jan;182:105905. doi: 10.1016/j.neuint.2024.105905. Epub 2024 Nov 19.

The role of ferritinophagy and ferroptosis in Alzheimer's disease

Chen Z, Zheng N, Wang F, Zhou Q, Chen Z, Xie L, Sun Q, Li L, Li B.

Brain Res. 2025 Mar 1;1850:149340. doi: 10.1016/j.brainres.2024.149340. Epub 2024 Nov 23.

Recent advances in Alzheimer's disease therapy: clinical trials and literature review of novel enzyme inhibitors targeting amyloid precursor protein

Antony D, Sheth P, Swenson A, Smoller C, Maguire K, Grossberg G.

Expert Opin Pharmacother. 2025 Jan;26(1):63-73. doi: 10.1080/14656566.2024.2438317. Epub 2024 Dec 4.

An overview on the impact of viral pathogens on Alzheimer's disease

AmeliMojarad M, AmeliMojarad M, Cui X.

Ageing Res Rev. 2025 Feb;104:102615. doi: 10.1016/j.arr.2024.102615. Epub 2024 Dec 2.

The emerging roles of particulate matter-changed non-coding RNAs in the pathogenesis of Alzheimer's disease: A comprehensive in silico analysis and review

Zeng HX, Qin SJ, Andersson J, Li SP, Zeng QG, Li JH, Wu QZ, Meng WJ, Oudin A, Kanninen KM, Jalava P, Dong GH, Zeng XW.

Environ Pollut. 2025 Feb 1;366:125440. doi: 10.1016/j.envpol.2024.125440. Epub 2024 Dec 2.

Advances in the structural modification of Alzheimer's disease drug - Huperzine A

Zhu X, Xu JB, Gao F, Wan LX.

Bioorg Chem. 2025 Jan;154:108012. doi: 10.1016/j.bioorg.2024.108012. Epub 2024 Nov 29.

Targeted protein degradation with bifunctional molecules as a novel therapeutic modality for Alzheimer's disease & beyond

Sandhof CA, Murray HFB, Silva MC, Haggarty SJ.

Neurotherapeutics. 2025 Apr;22(3):e00499. doi: 10.1016/j.neurot.2024.e00499. Epub 2024 Dec 4.

Exerkines mitigating Alzheimer's disease progression by regulating inflammation: Focusing on macrophage/microglial NLRP3 inflammasome pathway

Cheon J, Kwon S, Kim M.

Alzheimers Dement. 2025 Feb;21(2):e14432. doi: 10.1002/alz.14432. Epub 2024 Dec 6.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias